IL217360A0 - Assessment of blood-brain barrier disruption - Google Patents
Assessment of blood-brain barrier disruptionInfo
- Publication number
- IL217360A0 IL217360A0 IL217360A IL21736012A IL217360A0 IL 217360 A0 IL217360 A0 IL 217360A0 IL 217360 A IL217360 A IL 217360A IL 21736012 A IL21736012 A IL 21736012A IL 217360 A0 IL217360 A0 IL 217360A0
- Authority
- IL
- Israel
- Prior art keywords
- assessment
- blood
- brain barrier
- barrier disruption
- disruption
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL217360A IL217360A (en) | 2007-05-16 | 2012-01-04 | System for disrupting blood-brain barrier |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92447407P | 2007-05-16 | 2007-05-16 | |
PCT/IL2008/000673 WO2008139480A2 (en) | 2007-05-16 | 2008-05-15 | Assessment of blood-brain barrier disruption |
IL217360A IL217360A (en) | 2007-05-16 | 2012-01-04 | System for disrupting blood-brain barrier |
Publications (2)
Publication Number | Publication Date |
---|---|
IL217360A0 true IL217360A0 (en) | 2012-02-29 |
IL217360A IL217360A (en) | 2014-02-27 |
Family
ID=45855259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL217360A IL217360A (en) | 2007-05-16 | 2012-01-04 | System for disrupting blood-brain barrier |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL217360A (en) |
-
2012
- 2012-01-04 IL IL217360A patent/IL217360A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL217360A (en) | 2014-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL237391A0 (en) | Pharmaceutical combination | |
EP2240022A4 (en) | Pharmaceutical compositions | |
GB0814695D0 (en) | Pharmaceutical compositions | |
EP2373681A4 (en) | Pharmaceutical compositions | |
GB0808835D0 (en) | Therapeutic compositions | |
HK1152640A1 (en) | Pharmaceutical combination | |
HU0800591D0 (en) | Stable pharmaceutical combination | |
GB0815315D0 (en) | Organ protection | |
ZA201100282B (en) | Improved barrier | |
GB0819958D0 (en) | Therapeutic compositions | |
IL206487A0 (en) | Pharmaceutical compositions | |
GB2462354B (en) | Barrier | |
GB0816532D0 (en) | Barrier | |
IL217360A0 (en) | Assessment of blood-brain barrier disruption | |
IL202118A0 (en) | Assessment of blood-brain barrier disruption | |
HU0800414D0 (en) | Pharmaceutical combination | |
GB0800659D0 (en) | Pharmaceutical Compositions | |
GB0814313D0 (en) | Barrier | |
GB0801505D0 (en) | Barrier | |
GB0801073D0 (en) | Goalmouth barrier | |
GB0818146D0 (en) | Barrier | |
AU323520S (en) | Barrier | |
AU323519S (en) | Barrier | |
GB0700152D0 (en) | Analgesic | |
AU2009905565A0 (en) | Improved Barrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |